Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Ïñèõîòåðàïèÿ, ïñèõèàòðèÿ è íàðêîëîãèÿ > Îáùåíèå ñïåöèàëèñòîâ

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #31  
Ñòàðûé 04.11.2011, 01:17
Àâàòàð äëÿ Eugenikom
Eugenikom Eugenikom âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 04.01.2011
Ãîðîä: Êàëèíèíãðàä
Ñîîáùåíèé: 538
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 165 ðàç(à) çà 153 ñîîáùåíèé
Eugenikom ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåEugenikom ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåEugenikom ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåEugenikom ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Äîïîëíèòåëüíî ñîîáùàþ, â Êàëèíèíãðàäñêîé îáëàñòè ÷èñëåííîñòü íàñåëåíèÿ ïîðÿäêà 960000, êîëè÷åñòâî ÂÈ× èíôèöèðîâàííûõ ïîðÿäêà 6000 (òî÷íî íå ïîìíþ) Âûÿâëÿåìîñòü ÂÈ× íà ñåãîäíÿøíèé äåíü ìåíüøå, õóæå ñ ãåïàòèòîì Ñ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #32  
Ñòàðûé 04.11.2011, 01:22
Àâàòàð äëÿ Eugenikom
Eugenikom Eugenikom âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 04.01.2011
Ãîðîä: Êàëèíèíãðàä
Ñîîáùåíèé: 538
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 165 ðàç(à) çà 153 ñîîáùåíèé
Eugenikom ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåEugenikom ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåEugenikom ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåEugenikom ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ñòàòèñòèêà ïî Êàëèíèíãðàäñêîé îáëàñòè íà 1 èþëÿ 2009 ã. ïî ÂÈ× – èíôåêöèè.

Êîëè÷åñòâî ÂÈ× – èíôèöèðîâàííûõ, ïðîæèâàþùèõ íà äàííûé ìîìåíò â îáëàñòè

3925 ÷åë.

×èñëî çàðåãèñòðèðîâàííûõ íîâûõ ñëó÷àåâ (çà 6 ìåñ. 2009 ã.)

256 ÷åë. (íà 17,2% áîëüøå, ÷åì â 2008 ã.)

èç íèõ: ìóæ÷èí: 148 ÷åë.
æåíùèí: 108 ÷åë.

Ïóòè çàðàæåíèÿ: â/â íàðêîòè÷åñêèé – 62 ÷åë. (26,2%)

ïîëîâîé – 190 ÷åë.(73,1%)
ãîìîñåêñóàëüíûé: 1 ÷åë.

Óìåðëî ÂÈ× – èíôèöèðîâàííûõ: 82 ÷åë.
â ò. ÷. îò ÑÏÈÄà: 16 ÷åë.

Íà ÀР– òåðàïèè: îêîëî 1000 ÷åë.

 ÌËÑ - îñóæäåííûõ â Êàëèíèíãðàäñêîé îáëàñòè – 4, 585 ÷åë.
Èç íèõ ÂÈ× – èíôèöèðîâàííûõ – 472 ÷åë. (ñðåäè íèõ íà ÀР– òåðàïèè îêîëî 100 ÷åë.)
Îòâåòèòü ñ öèòèðîâàíèåì
  #33  
Ñòàðûé 04.11.2011, 09:02
Àâàòàð äëÿ duel
duel duel âíå ôîðóìà
êëèíè÷åñêèé ïñèõîëîã
      
 
Ðåãèñòðàöèÿ: 19.01.2010
Ãîðîä: Áåëàðóñü, Ñîëèãîðñê
Ñîîáùåíèé: 2,420
Ñêàçàë(à) ñïàñèáî: 25
Ïîáëàãîäàðèëè 910 ðàç(à) çà 602 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 4
duel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåduel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåduel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåduel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåduel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåduel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåduel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåduel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåduel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåduel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåduel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
À êàê îáñòîÿò äåëà â Áåëàðóñèè? Ó Âàñ ðàáîòàåò ïðîãðàììà ïî ñíèæåíèþ âðåäà?
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Öèòàòà:
Ýïèäñèòóàöèÿ ïî ÂÈ×-èíôåêöèè â Ðåñïóáëèêå Áåëàðóñü íà 1 îêòÿáðÿ 2011 ãîäà

Ïî ñîñòîÿíèþ íà 1 îêòÿáðÿ 2011ã. â Ðåñïóáëèêå Áåëàðóñü çàðåãèñòðèðîâàíî 12 648 ñëó÷àåâ ÂÈ×-èíôåêöèè (ïîêàçàòåëü ðàñïðîñòðàíåííîñòè ñîñòàâèë 106,4 íà 100 òûñÿ÷ íàñåëåíèÿ). Çà 9 ìåñÿöåâ 2011ã. âûÿâëåíî 889 ÂÈ×-èíôèöèðîâàííûõ (9 ìåñÿöåâ 2010ã. – 786). Òåìï ðîñòà ñîñòàâèë 13,1%. Ïîêàçàòåëü çàáîëåâàåìîñòè – 9,4 íà 100 òûñÿ÷ íàñåëåíèÿ (9 ìåñÿöåâ 2010 ã. – 8,3).

 Ãîìåëüñêîé îáëàñòè çàðåãèñòðèðîâàíî 6328 ñëó÷àåâ ÂÈ×-èíôåêöèè (ïîêàçàòåëü ðàñïðîñòðàíåííîñòè ñîñòàâèë 330,4), Ìèíñêîé îáëàñòè 1 704 (102,6), ã. Ìèíñêå 1 799 (85,5), Ìîãèëåâñêîé îáëàñòè 713 (55,6) Áðåñòñêîé îáëàñòè 934 (53,6), Âèòåáñêîé îáëàñòè 658 (44,7), Ãðîäíåíñêîé îáëàñòè 512 (38,3).

Ïîäàâëÿþùåå ÷èñëî ÂÈ×-èíôèöèðîâàííûõ - ýòî ìîëîäûå ëþäè â âîçðàñòå îò 15 äî 29 ëåò. Îáùåå êîëè÷åñòâî ñëó÷àåâ ÂÈ×-èíôåêöèè â ýòîé âîçðàñòíîé ãðóïïå ñîñòàâëÿåò 7 866 (óäåëüíûé âåñ â îáùåé ñòðóêòóðå ÂÈ×-èíôèöèðîâàííûõ - 62,2%).

Óäåëüíûé âåñ ëèö â âîçðàñòíîé ãðóïïû 15-19 ëåò â îáùåé ñòðóêòóðå ÂÈ×-èíôèöèðîâàííûõ çà 9 ìåñÿöåâ 2011ã. ñîñòàâèë 1,3% (9 ìåñÿöåâ 2010ã. - 2,0%).

Ïî êóìóëÿòèâíûì äàííûì (1987-01.10.2011ã.) 47,8% (6049 ÷åëîâåê) èíôèöèðîâàííûõ âèðóñîì èììóíîäåôèöèòà ÷åëîâåêà çàðàçèëèñü ïàðåíòåðàëüíûì ïóòåì (ïðè âíóòðèâåííîì ââåäåíèè íàðêîòè÷åñêèõ âåùåñòâ), óäåëüíûé âåñ ëèö, èíôèöèðîâàíèå êîòîðûõ ïðîèçîøëî ïîëîâûì ïóòåì, ñîñòàâëÿåò 49,6% (6273 ñëó÷àÿ).

Çà 9 ìåñÿöåâ 2011ã. äîëÿ ïàðåíòåðàëüíîãî ïóòè ïåðåäà÷è ÂÈ× ñîñòàâèëà 21,4% (190 ÷åë.), â 2010 ã. 154 ÷åë.–19,6%; ïîëîâîé ïóòü - 75,6% (672 ÷åë.), â 2010 ã.- 76,0% (597).

 öåëîì ïî ðåñïóáëèêå óäåëüíûé âåñ æåíùèí èç îáùåãî ÷èñëà ÂÈ×-èíôèöèðîâàííûõ ñîñòàâëÿåò 38,9% (4920 ÷åë.), ìóæ÷èí – 61,1% (7728 ÷åë.). Çà 9 ìåñÿöåâ 2011ã. óäåëüíûé âåñ æåíùèí - 47,2% (420 ÷åë.), ìóæ÷èí - 52,8 % (469 ÷åë.).

Ñ 1987 ïî 01.10.2011 ã. îò ÂÈ×-èíôèöèðîâàííûõ ìàòåðåé ðîäèëîñü 1 909 äåòåé, â òîì ÷èñëå çà 9 ìåñÿöåâ 2011ã. – 130 (9 ìåñÿöåâ 2010ã. -170).

Äèàãíîç «ÂÈ×-èíôåêöèÿ» ïîäòâåðæäåí 196 äåòÿì (çà 9 ìåñÿöåâ 2011ã - 21) , èç íèõ 9 óìåðëî. Âñåãî â ðåñïóáëèêå ñðåäè äåòåé â âîçðàñòíîé ãðóïïå îò 0 äî 14 ëåò çàðåãèñòðèðîâàíî 211 ñëó÷àåâ ÂÈ×-èíôåêöèè.

Êóìóëÿòèâíîå ÷èñëî ñëó÷àåâ ÑÏÈÄà íà 01.10.2011ã. – 2 867, â òîì ÷èñëå çà 9 ìåñÿöåâ 2011ã. äàííûé äèàãíîç óñòàíîâëåí 432 ïàöèåíòàì (çà àíàëîãè÷íûé ïåðèîä 2010 ã. - 433).

Ñðåäè ÂÈ×-èíôèöèðîâàííûõ ïàöèåíòîâ óìåðëî 2535 ÷åëîâåê (â òîì ÷èñëå â ñòàäèè ÑÏÈÄà - 1355). Çà 9 ìåñÿöåâ 2011ã. óìåðëî 291 ÷åëîâåê (9 ìåñÿöåâ 2010ã.-260), â òîì ÷èñëå â ñòàäèè ÑÏÈÄà -172 (9 ìåñÿöåâ 2010ã.-171).

Äàííûå ïðåäîñòàâëåíû: Îòäåë ïðîôèëàêòèêè ÂÈ×/ÑÏÈÄ ÃÓ «Ðåñïóáëèêàíñêèé öåíòð ãèãèåíû, ýïèäåìèîëîãèè è îáùåñòâåííîãî çäîðîâüÿ» >>>
Ïðîãðàììà Ñíèæåíèÿ Âðåäà ðàáîòàåò. Íî âîò ïðîãðàììà çàìåñòèòåëüíîé òåðàïèè íà÷àòà òîëüêî ñ íà÷àëà ýòîãî ãîäà, ïîýòîìó î ðåçóëüòàòàõ ðàáîòû ýòîé ïðîãðàììû â Áåëàðóñè ãîâîðèòü ïîêà ðàíî (õîòÿ ïèëîòíûé ïðîåêò â Ãîìåëå ðàáîòàë ñ 2008 ãîäà, åñëè ìíå ïàìÿòü íå èçìåíÿåò).

Öèòàòà:
ëåãàëèçàöèÿ íàðêîòèêîâ çëî âäâîéíå.
Óòâåðæäåíèå âåñüìà ñïîðíîå.
Öèòàòà:
Íàçíà÷åíèå íàðêîòè÷åñêèõ ñðåäñòâ çàâèñèìûì íå â êà÷åñòâå ëåêàðñòâà, à â êà÷åñòâå ñðåäñòâà óìåíüøàþùåãî âðåä, åù¸ áîëüøåå çëî.
Óòâåðæäåíèå, ñïîðíîå âäâîéíå.

Âàøå ëè÷íîå ìíåíèå - íå èñòèíà â ïîñëåäíåé èíñòàíöèè, îñîáåííî åñëè îíî ïðîòèâîðå÷èò ìåæäóíàðîäíûì íàó÷íûì äàííûì. Ïîäóìàéòå íàä ýòèì.
__________________
Ñ óâàæåíèåì, Åëèçàâåòà Äóíàåâà - Âàø ïñèõîëîã â Ñîëèãîðñêå
www.dunaeva.club
Îòâåòèòü ñ öèòèðîâàíèåì
  #34  
Ñòàðûé 04.11.2011, 10:45
BBC BBC âíå ôîðóìà
ìîäåðàòîð ôîðóìà
      
 
Ðåãèñòðàöèÿ: 15.08.2005
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 31,518
Ïîáëàãîäàðèëè 4,832 ðàç(à) çà 3,086 ñîîáùåíèé
BBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåBBC ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Eugenikom, Âû æå ïîïðîùàëèñü... ?
__________________
Ñ óâàæåíèåì,
Âàëåðèé Âàëåðüåâè÷ Ñàìîéëåíêî
Îòâåòèòü ñ öèòèðîâàíèåì
  #35  
Ñòàðûé 04.11.2011, 16:47
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,318
Ïîáëàãîäàðèëè 33,198 ðàç(à) çà 31,548 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ñïàñèáî çà öèôðû ïî ÂÈ× ñòàòèñòèêå â îáëàñòè, íî ïîçâîëüòå âåðíóòüñÿ ê íàðêîëîãèè...

ñîãëàñíî öèôðàì îòñþäà, ÷àñòîòà åæåãîäíîé ñìåðòíîñòè ñðåäè íàðêîìàíîâ â Ðîññèè ïðèìåðíî 6-20 íà 1000 â ãîä (30 000 - 100 000 ñìåðòåé â ãîä íà 5 ìëí. ïðèíèìàþùèõ íàðêîòèêè) [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

ïðèìåðíî òàêàÿ æå ñìåðòíîñòü (5-6 íà òûñÿ÷ó â ãîä) îò ïåðåäîçèðîâêè íàáëþäàåòñÿ è â ìèðå ñðåäè óïîòðåáëÿþùèõ ãåðîèí, ãåðîèíîâûå íàðêîìàíû, íàõîäÿùèåñÿ íà ïîääåðæèâàþùåì ëå÷åíèè ìåòàäîíîì óìèðàþò â 2-4 ðàçà ðåæå...

 Ðîññèè îñîáûé ïóòü - è ïðè ïîääåðæêå îòå÷åñòâåííûõ ïðîèçâîäèòåëåé òàáëåòî÷åê îò êàøëÿ ãåðîèíîâûå íàðêîìàíû ìàññîâî ïåðåõîäÿò íà äåçîìîðôèí - öåíà/êà÷åñòâî ïðîñòî íåñðàâíèìà: 50 óå çà äîçó ãåðîèíà èëè 2 óå çà äîçó êðîêîäèëà [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

ïðàâäà ñìåðòíîñòü êîíå÷íî ïîäâåëà - óâåëè÷èëàñü êàê ìèíèìóì â 6 ðàç ïðè ñðåäíåé ïðîäîëæèòåëüíîñòè æèçíè íàðêîìàíà 2-5 ëåò, íî çàòî êàêàÿ ïîääåðæêà îòå÷åñòâåííîãî ïðîèçâîäèòåëÿ - êîäåèí-ñîäåðæàùèå òàáëåòêè áüþò ðåêîðäû ïðîäàâàåìîñòè è äâîå èç òàêèõ ëåêàðñòâ â äåñÿòêå ñàìûõ ïîêóïàåìûõ â Ðîññèè...

ïî ïîâîäó ìåòàäîíà - äà, äåéñòâèòåëüíî, ÷èñëî ñìåðòåé îò íåãî âîçðàñòàåò èç ãîäà â ãîä, íî áîëüøèíñòâî èç íèõ - ñëó÷àéíîñòè, òîãäà òàê äîëÿ ñìåðòåé ñðåäè íàõîäÿùèõñÿ íà ïîääåðæèâàþùåé òåðàïèè âñåãî 3%:

The manners of death were classified as follows: 84% accident, 12% undetermined, and 4% suicide... The proportion of methadone-related deaths has increased by 300% from 2001 (0.6% of reported deaths, 12% of overdose deaths) to 2006 (3% of reported deaths, 37% of overdose deaths)... Methadone maintenance therapy for heroin dependence in our population comprises an insignificant number of the methadone-related deaths (3% of the decedents).
Èç
Am J Forensic Med Pathol. 2011 Jun;32(2):131-5.
The methadone epidemic: methadone-related deaths on the rise in Vermont.

Êîììåíòàðèè ê ñîîáùåíèþ:
Aminazinka îäîáðèë(à):
duel îäîáðèë(à):
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #36  
Ñòàðûé 04.11.2011, 17:25
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,318
Ïîáëàãîäàðèëè 33,198 ðàç(à) çà 31,548 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
È åùå íåìíîãî íàãëÿäíîñòåé ïî Êàëèíèíãðàäó è îáëàñòè - ïðîñòî ïåðåäîâîé ôëàãìàí Ðîññèè:

ó÷èòûâàÿ ñòàáèëüíûé 9% åæåãîäíûé ðîñò ïî îáëàñòè è íàñåëåíèå â 960 òûñÿ÷ íà 2009 ã. ÷èñëî ÂÈ× èíôèöèðîâàííûõ äîëæíî ñîñòàâëÿòü îêîëî 7 000, à Âû óêàçûâàåòå "Êîëè÷åñòâî ÂÈ× – èíôèöèðîâàííûõ, ïðîæèâàþùèõ íà äàííûé ìîìåíò â îáëàñòè - 3925 ÷åë." - ïî÷òè ïîëîâèíà ñüåõàëà èëè óìåðëà?

Number of IDUs in the Kaliningrad region (01.01.2006)
2,360 – officially registered IDUs
1,010 – IDUs, who have undergone anonymous treatment
23,000 – actual number of drug users including IDUs estimated by experts

ãðàôèê è öèôðû âçÿòû èç

Legal and Policy Barriers to Effective Health Interventions among IDUs in Kaliningrad, Russia
---
Inna Vyshemirskaya (1), Alexander Koss (2), Victoria Osipenko (1), Olga Burkhanova (3), Zita Lazzarini (4)(7), Scott Burris (5),(7), Patricia Case (6)
(1) Kaliningrad NGO Young Leaders Army, Russia (2) Immanuel Kant’s University of Russia, (3) Kaliningrad NGO Help Now, Russia, (4) University of Connecticut Health Center, USA (5) Temple University Beasley School of Law, USA (6) Fenway Community Health Center, USA (7) Center for Law and the Public’s Health at Georgetown and Johns Hopkins Universities, USA

ðàçìåùåííóþ â ñâîá. äîñòóïå íà ñàéòå Temple University
Èçîáðàæåíèÿ
Òèï ôàéëà: jpg Picture1.jpg (26.2 Êá, 73 ïðîñìîòðîâ)
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #37  
Ñòàðûé 04.11.2011, 19:03
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,318
Ïîáëàãîäàðèëè 33,198 ðàç(à) çà 31,548 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
åùå ïî ïðîáëåìå ãåðîèíîâîé çàâèñèìîñòè â Ðîññèè (íà 2005 ãîä) â íîðìàëüíîé ïåðèîäèêå - îòòóäà ïàðî÷êà ôðàç:

The WHO has supplied the following basic parameters relevant to HIV in Russia within the main groups at risk:
Estimated number of intravenous drug users: 1.5-3.5 million.
IDUs among PLWHA: 85% (Euro-WHO review, December 2004).
IDUs on ARV treatment: 50% (Euro-WHO review, December 2004).
Prevalence of HIV among intravenous drug users in some cities as high as 65%.

According to official statistics, 70,000 (20%) of patients with drug abuse die each year as a result of overdoses or other causes (by comparison, 40,000 patients with alcohol dependency die annually).

Perhaps because methadone is considered to be an illicit drug that is prohibited in the territory of the Russian Federation, a memorandum has
been issued, stating: “Say no to methadone programmes in the Russian Federation (methadone prescription cannot be considered a treatment)”. Still, the position of the
WHO has not changed, in view of the pandemic situation affecting intravenous drug users in Russia. According to the WHO, substitution therapy is an effective tool in
programmes of harm reduction, now that the proportion of intravenous drug users among HIV-infected patients has nearly reached 80%. Substitution therapy will also
lead to a reduction in illicit opiate consumption, criminal activity, and the number of lethal overdoses. In addition, the WHO considers substitution therapy to be a powerful
tool in achieving ARV therapy compliance by intravenous drug users (which allows an improvement in general health among HIV-infected intravenous drug users), a
treatment method that is more effective than placebo or detoxification alone, and also helps patients to resocialize.

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #38  
Ñòàðûé 04.11.2011, 23:10
Àâàòàð äëÿ Eugenikom
Eugenikom Eugenikom âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 04.01.2011
Ãîðîä: Êàëèíèíãðàä
Ñîîáùåíèé: 538
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 165 ðàç(à) çà 153 ñîîáùåíèé
Eugenikom ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåEugenikom ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåEugenikom ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåEugenikom ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Âàäèì Âàëåðüåâè÷, à ÷òî âû äóìàåòå ïî ýòîìó ïîâîäó: Ïî äàííûì Óïðàâëåíèÿ ïî íàðêîòèêàì è ïðåñòóïíîñòè ÎÎÍ, âñå áîëüøå ëþäåé â ìèðå ïîòðåáëÿþò ñàìûå îïàñíûå íàðêîòèêè - êîêàèí, ãåðîèí, ìîðôèé è äðóãèå. Ïî äàííûì çà 2009 ãîä, â ìèðå çàôèêñèðîâàíî îêîëî 200 ìëí. ÷åëîâåê, óïîòðåáëÿþùèõ íàðêîòèêè.
Ïî ñðàâíåíèþ ñ äðóãèìè ñòðàíàìè èìåííî â ÑØÀ íàèáîëüøåå êîëè÷åñòâî íàðêîçàâèñèìûõ - 56% íàðêîìàíîâ ìèðà çàðåãèñòðèðîâàíû èìåííî â Ñîåäèíåííûõ Øòàòàõ Àìåðèêè, à ýòî 12% îò îáùåãî íàñåëåíèÿ ÑØÀ, ïî äàííûì çà 2009 ãîä - îêîëî 17, 5 ìëí. ÷åëîâåê.
Íàðêîìàíû ÑØÀ óïîòðåáëÿþò îêîëî 86% âñåõ íàðêîòèêîâ, ïðîèçâåäåííûõ â ìèðå. Ïðåñòóïëåíèÿ, ñîâåðøåííûå íàðêîìàíàìè, - êðàæè, ãðàáåæè è óáèéñòâà, ñîñòàâëÿþò äî ïîëîâèíû îò îáùåãî êîëè÷åñòâà.
Ïî êîëè÷åñòâó ÂÈ×-èíôèöèðîâàííûõ íàðêîìàíîâ ÑØÀ çàíèìàåò âòîðîå ìåñòî â ìèðå - 22% (íà ïåðâîì ìåñòå - Ðîññèÿ, çäåñü 74% îôèöèàëüíî çàðåãèñòðèðîâàííûõ íàðêîìàíîâ èìååò ïîëîæèòåëüíûé ÂÈ×-ñòàòóñ ïî äàííûì çà 2008 ãîä).
Ïîëèòèêà ÑØÀ, íàïðàâëåííàÿ ïðîòèâ ðàñïðîñòðàíåíèÿ íàðêîòèêîâ, ïðèìåíÿåò äîâîëüíî æåñòêèå ìåðû äëÿ íàðêîìàíîâ - çäåñü ìîæíî ïîëó÷èòü ñðîê íå òîëüêî çà óïîòðåáëåíèå èëè õðàíåíèå íàðêîòèêîâ, íî è çà ïîïûòêó èõ ïðèîáðåñòè. Àíòèíàðêîòè÷åñêàÿ ïðîãðàììà ÑØÀ ïðîèñõîäèò ïî äâóì íàïðàâëåíèÿì: ñòðåìëåíèå ñîêðàùàòü ïîòðåáëåíèå íàðêîòèêîâ ïóòåì ïðîïàãàíäû è ðàçúÿñíèòåëüíîé ðàáîòû; è îãðàíè÷åíèå èíîñòðàííûõ ïîñòàâîê íàðêîòèêîâ. Ïî÷åìó â ñòðàíå, ãäå òàê óñïåøíî ëå÷àò íàðêîìàíèè òàêèå ïðîáëåììû.
Ñâåäåíèÿ êîòîðûå âû ïðåäñòàâèëè î ñòàòèñòèêå ðîñòà ÂÈ× èíôèöèðîâàííûõ â Êàëèíèíãðàäñêîé îáëàñòè íå ñîîòâåòñòâóþò äåéñòâèòåëüíîñòè, åñëè ãîâîðèòü î êîëè÷åñòâå ëàáîðàòîðíî ïîäòâåðæä¸ííûõ ñëó÷àÿõ âè÷ èíôåêöèè ( ïðî÷èòàâ èñòî÷íèêè èíôîðìàöèè, âñòðåòèë ôàìèëèþ ïðåäñòàâèòåëÿ îáùåñòâåííîé îðãàíèçàöèè ÞËÀ, íå ñîìíåâàþñü, ÷òî îíà çíàåò îôèöèàëüíóþ ñòàòèñòèêó, íà äíÿõ ïîèíòåðåñóþñü,îòêóäà òàêèå äàííûå.
Ïî ïðèâåä¸ííûì âûøå äàííûì ìîæíî ïðåäïîëîæèòü, ÷òî êîëè÷åñòâî ÂÈ× èíôèöèðîâàííûõ íà ñåãîäíÿøíèé äåíü ñîñòàâëÿåò ïîðÿäêà 6000 (èç íèõ ïîðÿäêà 4000 èíúåêöèîííûõ ïîòðåáèòåëåé), ïóñòü Âû ïðàâû 7000, ýòî ïîðÿäêà 0,7% îò âñåãî íàñåëåíèÿ Êàëèíèíãðàäñêîé îáëàñòè ïî ñðàâíåíèþ ñ ÑØÀ ãîðàçäî ìåíüøå
Ïî ïîâîäó äàííûõ ñòàòèñòèêè â Ðîññèè íåò ÷åëîâåêà, êîòîðûé õîòÿ áû ðàç íå ïðîõîäèë îáñëåäîâàíèå íà ÂÈ×, à â ÑØÀ? Êàê âû îáúÿñíèòå ðàñïðîñòðàí¸ííîñòü íàðêîìàíèè â ÑØÀ? Áóçóñëîâíî â ÑØÀ åñòü óñïåõè ïî áîðüáå ñ çàâèñèìîñòÿìè, íî îíè îòíþäü íå ñâÿçàíû ñ ìåäèöèíñêèì àñïåêòîì, ê ñîæàëåíèþ.
×òî êàñàåòñÿ äåçîìîðôèíà,òî çëîãî óìûñëà ôàðìàöåâòè÷åñêèõ êîìïàíèé íåò. Áåñïîðÿäîê íà àïòå÷íîì ðûíêå, áåçðåöåïòóðíûé îòïóñê ëåêàðñòâ è ò.ä.
 ïðîãðàììàõ ñíèæåíèÿ âðåäà êîíå÷íî åñòü çäðàâûé ñìûñë, íî çàìåñòèòåëüíàÿ òåðàïèÿ âîçìîæíà â êðàéíå îãðàíè÷åííûõ ñëó÷àÿõ â óñëîâèÿõ ìåäèöèíñêîãî ó÷ðåæäåíèÿ è íå ìåòàäîíîì.
Ñ óâàæåíèåì!
Åâãåíèé Íèêîëàåâè÷.

Äîáàâëþ ïî ïîâîäó ñòîèìîñòè ãåðîèíà â Ðîññèè, ê ñîæàëåíèþ ñòîèìîñòü óñëîâíîé äîçû ãåðîèíà ãîðàçäî äåøåâëå, ÷åì ïðèâîäèòå Âû, ïðîøåäøèì ëåòîì 200 (7 äîëëàðîâ) ðóáëåé, à ñåé÷àñ 500-600 ðóáëåé.
Îòâåòèòü ñ öèòèðîâàíèåì
  #39  
Ñòàðûé 04.11.2011, 23:36
Àâàòàð äëÿ elisey
elisey elisey âíå ôîðóìà ÂÐÀ×
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 23.11.2008
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 603
Ñêàçàë(à) ñïàñèáî: 6
Ïîáëàãîäàðèëè 263 ðàç(à) çà 169 ñîîáùåíèé
elisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ñàìè è îòâå÷àåòå.

Öèòàòà:
Êàê âû îáúÿñíèòå ðàñïðîñòðàí¸ííîñòü íàðêîìàíèè â ÑØÀ?
Öèòàòà:
Ñîîáùåíèå îò Eugenikom Ïîñìîòðåòü ñîîáùåíèå
Ïîëèòèêà ÑØÀ, íàïðàâëåííàÿ ïðîòèâ ðàñïðîñòðàíåíèÿ íàðêîòèêîâ, ïðèìåíÿåò äîâîëüíî æåñòêèå ìåðû äëÿ íàðêîìàíîâ - çäåñü ìîæíî ïîëó÷èòü ñðîê íå òîëüêî çà óïîòðåáëåíèå èëè õðàíåíèå íàðêîòèêîâ, íî è çà ïîïûòêó èõ ïðèîáðåñòè
Çíàìåíèòû äîêëàä ÎÎÍ ñ ïðåäëîæåíèåì ëåãàëèçàöèè è äåêðèìèíàëèçàöèè áûë îáðàùåí èìåííî ê ÑØÀ.  ïåðâóþ î÷åðåäü ê ÑØÀ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #40  
Ñòàðûé 04.11.2011, 23:52
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,318
Ïîáëàãîäàðèëè 33,198 ðàç(à) çà 31,548 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Åâãåíèé Íèêîëàåâè÷, õîòåëîñü áû óâèäåòü ññûëêó íà öèòèðóåìûé Âàìè ôðàãìåíò, èáî ïðîñòûå ïîäñ÷åòû "íå ïëÿøóò":

There were 155.6 million females in the United States in 2009. The number of males was 151.4 million - èòîãî 307 ìèëëèîíîâ, åñëè íàðêîìàíîâ â ÑØÀ áûëî 17.5 ìèëëèîíîâ, òî 17.5/307 õ100% äàåò âñåãî 6% íî íèêàê íå 12%, íà ñàìîì äåëå æå öèôðû ñëåäóþùèå:

Some highlights, all based on the 2006 and 2007 National Surveys on Drug Use and Health’s data on people age 12 or older:

Across the United States, 8.1% of people had used an illicit drug in the last month. Illicit drug use was lowest in Iowa (5.2 percent in the last month) and highest in Rhode Island (12.5 percent). (Here “illicit drugs” includes “marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically.”)

êàçàëîñü áû è öèôðà 8% âïå÷àòëÿåò, íî åñëè îòáðîñèòü ìàðèõóàíó: The percentage of people who used illicit drugs besides marijuana in the last month was 3.8%. Rates were lowest in Iowa, North Dakota and South Dakota (2.6 percent). They were highest in Arizona and Rhode Island (5.5 percent).

À åñëè îòáðîñèòü êîêàèí è ëåêàðñòâà, èñïîëüçóåìûå ïî íåìåäèöèíñêèì ïîêàçàíèÿì, îñòàâëÿÿ â/â ãåðîèí è äð. îïèàòû, òî

"Based on the National Survey on Drug Use and Health conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA), misuse of opioids is prevalent in the U.S. with 4.7 million adolescents or adults misusing prescription opioids (POs) in the past month in 2008, which is about 2% of the total U.S. population of adolescents and adults [1]."

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

èëè îïèàòû ïðèíèìàþò 2% îò îáùåé ïîïóëÿöèè ïîäðîñòêîâ è âçðîñëûõ Àìåðèêè (äåòè ìëàäøå 12 ! ÍÅ âêëþ÷åíû),

ïî êàëèíèíãðàäñêîé îáëàñòè ýêñïåðòíûå îöåíêè ïî â/â íàðêîìàíàì íà 2006 ãîä: 23 òûñ ÷åëîâåê è íà âñå íàñåëåíèå îáëàñòè (âêëþ÷àÿ äåòåé) 960 000: 23/960 õ 100% = 2.4%

Êàêîé áûë ñìûñë â ìåðÿíüÿõ?

Ñìûñë äèñêóññèè â òîì, ÷òî ëþäåé ñïàñàòü íóæíî, à íå â èãðû èãðàòü íà "áîëüøå-ìåíüøå"

PS. öåíà ãåðîèíà áûëà âçÿòà èç ðîññèéñêîãî äîêëàäà (ññûëêà â ñîîáùåíèè 37, ñòð. 16): A long-term heroin user needs up to 1500 roubles (US$50) daily to buy drugs.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #41  
Ñòàðûé 04.11.2011, 23:58
Àâàòàð äëÿ elisey
elisey elisey âíå ôîðóìà ÂÐÀ×
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 23.11.2008
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 603
Ñêàçàë(à) ñïàñèáî: 6
Ïîáëàãîäàðèëè 263 ðàç(à) çà 169 ñîîáùåíèé
elisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïîðòóãàëèÿ.  2001 ãîäó áûëî äåêðèìèíàëèçèðîâàíî óïîòðåáëåíèå íàðêîòèêîâ (íî íå ëåãàëèçîâàíî). Òî åñòü õðàíåíèå íàðêîòèêîâ ñòàëî ïîäëåæàòü àäìèíèñòðàòèâíîìó íàêàçàíèþ, íî íå óãîëîâíîìó ïðåñëåäîâàíèþ. Ðåçóëüòàòû (ïî÷åìó-òî íå ìîãó îòêðûòü áîëåå ïîçäíèå äîêëàäû) -

2009 NATIONAL REPORT (2008 data) TO THE EMCDDA by the Reitox National Focal Point. ([Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ])


Conclusion
Considering the legal status of drug use in Portugal – decriminalization of drug use was implemented in 2001 – it is interesting to realize that drug use did not increase among young people, but instead the trend seems to be in the direction of the decrease either in the number of users (prevalence) or in the intensity of use (lower level of intensive use-more than 20 times in last 12 months) among the users.
On the other side, the perceptions of the risk of using drugs show a generalised increase of those considering that drug use presents a “high risk” despite the fact that the perception of access to the cannabis (and other substances) had increased.
The beliefs about being very difficult to quit the regular use also increased among the older students, perhaps translating a deeper knowledge about the effects and risks of cannabis use and being one of the possible explanations to the decrease in the prevalence of cannabis use.
Îòâåòèòü ñ öèòèðîâàíèåì
  #42  
Ñòàðûé 05.11.2011, 07:52
Àâàòàð äëÿ Eugenikom
Eugenikom Eugenikom âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 04.01.2011
Ãîðîä: Êàëèíèíãðàä
Ñîîáùåíèé: 538
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 165 ðàç(à) çà 153 ñîîáùåíèé
Eugenikom ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåEugenikom ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåEugenikom ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåEugenikom ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Âàäèì Âàëåðüåâè÷, öèôðû ïî ÑØÀ áûëè ïðèâåäåíû äëÿ ñðàâíåíèÿ ñ öåëüþ îöåíèòü ýôôåêòèâíîñòü ìåäèêîñîöèàëüíûõ ïðîãðàìì. Ñïàñàòü ëþäåé íóæíî, íî âîïðîñ êàê?
À ïî ïîâîäó öåí, âîò Âàì öåíà èíôîðìàöèè èç íåêîòîðûõ îôèöèàëüíûõ èñòî÷íèêîâ.
Ñ óâàæåíèåì!
Åâãåíèé Íèêîëàåâè÷
Îòâåòèòü ñ öèòèðîâàíèåì
  #43  
Ñòàðûé 05.11.2011, 17:48
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,318
Ïîáëàãîäàðèëè 33,198 ðàç(à) çà 31,548 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Åâãåíèé Íèêîëàåâè÷, âðÿä ëè ðåàëüíî ïîâëèÿòü íà âñòðå÷àåìîñòü òîé èëè èíîé íàðêîìàíèè ñðåäè íàñåëåíèÿ â òîé èëè èíîé ñòðàíå, ìåäèöèíñêàÿ çàäà÷à - ïîìî÷ü óæå îñòóïèâøèìñÿ, íî íå ïóòåì ëèøåíèÿ ñâîáîäû è ïðèêîâûâàíèÿ íàðó÷íèêàìè ê áàòàðåå íà ïåðèîä ëîìêè, à ñîãëàñíî èìåþùåìóñÿ ìåäèöèíñêîìó ýâèäåíñó - ìåòàäîí, áóïðåíîðôèí, íàëòðåêñîí. Ïîñìîòðèòå êàê ïèòåðñêèå êîëëåãè ïðèìåíÿþò íàëòðåêñîí â ðàçíûõ ôîðìàõ è êîìáèíàöèÿõ (êîìáèíàöèè, êñòàòè, íå ïðîÿâèëè ñåáÿ ëó÷øå ìîíîòåðàïèè íàëòðåêñîíîì) äëÿ ëå÷åíèÿ îïèàòíîé çàâèñèìîñòè:

Curr Psychiatry Rep. 2010 Oct;12(5):448-53.
Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available.
Krupitsky E, Zvartau E, Woody G.
Department of Addictions, St. Petersburg Bekhterev Psychoneurological Research Institute, St.-Petersburg, Russia

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #44  
Ñòàðûé 05.11.2011, 19:59
Àâàòàð äëÿ Eugenikom
Eugenikom Eugenikom âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 04.01.2011
Ãîðîä: Êàëèíèíãðàä
Ñîîáùåíèé: 538
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 165 ðàç(à) çà 153 ñîîáùåíèé
Eugenikom ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåEugenikom ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåEugenikom ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåEugenikom ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Èíòåðåñíàÿ èíôîðìàöèÿ. Ìû â ñâîåé ïðàêòèêå èñïîëüçóåì íàëòðåêñîí è ïðîëîíãè. Åäèíñòâåííûé ìèíóñ ýòî äîðîãîâèçíà ïðåïàðàòîâ. Íî íà ñåãîäíÿøíèé äåíü åñòü ìîðàëüíîå óäîâëåòâîðåíèå îò èñïîëüçîâàíèÿ ïðåïàðàòîâ ó õîðîøî ìîòèâèðîâàííûõ ïàöèåíòîâ. Ïðîëîíãè áîëåå ïðåäïî÷òèòåëüíû, ïîñêîëüêó ó çàâèñèìûõ ëþäåé, íà ïðîòÿæåíèè ïåðîðàëüíîãî ïðèåìà ïðåïàðàòà, ñëó÷àþòñÿ ìîòèâèðîâàííûå "áëàãèìè íàìåðåíèÿìè" ïðîïóñêè è êàê ñëåäñòâèå ðåöèäèâû. Íàñòîëüêî êîâàðíû êîìïóëüñèè. Íî ìîòèâèðîâàííûõ èç ñîòíè åäåíèöû, à ÷òî äåëàòü ñ îñòàëüíûìè? Õîðîøèé ýôôåêò äà¸ò íàëîêñîí â öåëÿõ ñîêðàùåíèÿ äëèòåëüíîñòè àáñòèíåíòíîãî ñèíäðîìà, íî âîçíèêàþò ñëîæíîñòè â óäåðæàíèè ïîöèåíòîâ â îòäåëåíèè.
Îòâåòèòü ñ öèòèðîâàíèåì
  #45  
Ñòàðûé 08.11.2011, 23:44
Àâàòàð äëÿ elisey
elisey elisey âíå ôîðóìà ÂÐÀ×
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 23.11.2008
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 603
Ñêàçàë(à) ñïàñèáî: 6
Ïîáëàãîäàðèëè 263 ðàç(à) çà 169 ñîîáùåíèé
elisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåelisey ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Ýïèäåìèîëîã î ïîëèòèêå, íàðêîòèêàõ, ñåêñå è ÂÈ×. Êîðîòêàÿ ëåêöèÿ, îñíîâàííàÿ íà èññëåäîâàíèÿõ, ñ ðóññêèìè ñóáòèòðàìè.

Êîììåíòàðèè ê ñîîáùåíèþ:
Aminazinka îäîáðèë(à):
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 17:56.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.